Skip to main content
. Author manuscript; available in PMC: 2016 Jan 29.
Published in final edited form as: Mol Diagn Ther. 2014 Dec;18(6):619–630. doi: 10.1007/s40291-014-0122-3

Fig. 2.

Fig. 2

Validation of antibody specificity. (a) Validated antibody: a western blot probed with anti-β-Arrestin 1/2 shows a dominant band at the expected molecular weight using a variety of commercially available cell lysates. (b) Non-validated antibody: a western blot probed with anti-erbB2 shows multiple bands at various molecular weights.